Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Wilms Tumor 1Stomach Neoplasms 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Malnutrition 1Hepatic Veno-Occlusive Disease 1Breast Neoplasms 1

Interventions

Oxaliplatin 10Fluorouracil 6Irinotecan 5Docetaxel 5Capecitabine 5tislelizumab 4S 1 (combination) 4Paclitaxel 4Endoscopic Mucosal Resection 4XELOX 3Levoleucovorin 3Laparoscopy 3Folfox protocol 3sintilimab 2apatinib 2Proton Pump Inhibitors 2Gastroenterostomy 2Gastrectomy 2Clarithromycin 2Chemotherapy, Adjuvant 2Amoxicillin 2vactosertib 1titanium silicide 1pembrolizumab 1lenvatinib 1durvalumab 1bismuth tripotassium dicitrate 1anlotinib 1Trastuzumab 1Tranexamic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Stomach Neoplasms × Hematologic Tests × Clear all
NCT04740346 2021-10-27

Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)

National Cancer Center, Korea

Phase NA Recruiting
886 enrolled
Gastrointestinal

Recurrence, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡